Risk-benefit ratio of sodium fluoride treatment in primary vertebral osteoporosis. 1988

N Mamelle, and P J Meunier, and R Dusan, and M Guillaume, and J L Martin, and A Gaucher, and A Prost, and G Zeigler, and P Netter
INSERM Unit 265, Lyon, France.

The risk-benefit ratio of combined fluoride-calcium therapy in primary vertebral osteoporosis was examined prospectively in patients with at least one vertebral fracture. 257 patients were randomised to receive sodium fluoride 25 mg twice daily plus elemental calcium 1 g daily and a vitamin D2 supplement, and 209 received one of the alternative therapies usually prescribed in France. After a follow-up of 24 months the fluoride-calcium group showed a significantly lower rate of new vertebral fractures, the main adverse effect of the regimen being a higher incidence of osteoarticular pains in the ankle and foot; the risk of non-vertebral fractures was not increased, and digestive disorders arose with equal frequency in the two groups. Sodium fluoride 50 mg daily seems to represent a reasonable compromise in terms of anti-fracture effectiveness and side-effects.

UI MeSH Term Description Entries
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D010024 Osteoporosis Reduction of bone mass without alteration in the composition of bone, leading to fractures. Primary osteoporosis can be of two major types: postmenopausal osteoporosis (OSTEOPOROSIS, POSTMENOPAUSAL) and age-related or senile osteoporosis. Age-Related Osteoporosis,Bone Loss, Age-Related,Osteoporosis, Age-Related,Osteoporosis, Post-Traumatic,Osteoporosis, Senile,Senile Osteoporosis,Osteoporosis, Involutional,Age Related Osteoporosis,Age-Related Bone Loss,Age-Related Bone Losses,Age-Related Osteoporoses,Bone Loss, Age Related,Bone Losses, Age-Related,Osteoporoses,Osteoporoses, Age-Related,Osteoporoses, Senile,Osteoporosis, Age Related,Osteoporosis, Post Traumatic,Post-Traumatic Osteoporoses,Post-Traumatic Osteoporosis,Senile Osteoporoses
D010146 Pain An unpleasant sensation induced by noxious stimuli which are detected by NERVE ENDINGS of NOCICEPTIVE NEURONS. Suffering, Physical,Ache,Pain, Burning,Pain, Crushing,Pain, Migratory,Pain, Radiating,Pain, Splitting,Aches,Burning Pain,Burning Pains,Crushing Pain,Crushing Pains,Migratory Pain,Migratory Pains,Pains, Burning,Pains, Crushing,Pains, Migratory,Pains, Radiating,Pains, Splitting,Physical Suffering,Physical Sufferings,Radiating Pain,Radiating Pains,Splitting Pain,Splitting Pains,Sufferings, Physical
D011897 Random Allocation A process involving chance used in therapeutic trials or other research endeavor for allocating experimental subjects, human or animal, between treatment and control groups, or among treatment groups. It may also apply to experiments on inanimate objects. Randomization,Allocation, Random
D002118 Calcium A basic element found in nearly all tissues. It is a member of the alkaline earth family of metals with the atomic symbol Ca, atomic number 20, and atomic weight 40. Calcium is the most abundant mineral in the body and combines with phosphorus to form calcium phosphate in the bones and teeth. It is essential for the normal functioning of nerves and muscles and plays a role in blood coagulation (as factor IV) and in many enzymatic processes. Coagulation Factor IV,Factor IV,Blood Coagulation Factor IV,Calcium-40,Calcium 40,Factor IV, Coagulation
D002986 Clinical Trials as Topic Works about pre-planned studies of the safety, efficacy, or optimum dosage schedule (if appropriate) of one or more diagnostic, therapeutic, or prophylactic drugs, devices, or techniques selected according to predetermined criteria of eligibility and observed for predefined evidence of favorable and unfavorable effects. This concept includes clinical trials conducted both in the U.S. and in other countries. Clinical Trial as Topic
D004334 Drug Administration Schedule Time schedule for administration of a drug in order to achieve optimum effectiveness and convenience. Administration Schedule, Drug,Administration Schedules, Drug,Drug Administration Schedules,Schedule, Drug Administration,Schedules, Drug Administration
D004341 Drug Evaluation Any process by which toxicity, metabolism, absorption, elimination, preferred route of administration, safe dosage range, etc., for a drug or group of drugs is determined through clinical assessment in humans or veterinary animals. Evaluation Studies, Drug,Drug Evaluation Studies,Drug Evaluation Study,Drug Evaluations,Evaluation Study, Drug,Evaluation, Drug,Evaluations, Drug,Studies, Drug Evaluation,Study, Drug Evaluation
D004359 Drug Therapy, Combination Therapy with two or more separate preparations given for a combined effect. Combination Chemotherapy,Polychemotherapy,Chemotherapy, Combination,Combination Drug Therapy,Drug Polytherapy,Therapy, Combination Drug,Chemotherapies, Combination,Combination Chemotherapies,Combination Drug Therapies,Drug Polytherapies,Drug Therapies, Combination,Polychemotherapies,Polytherapies, Drug,Polytherapy, Drug,Therapies, Combination Drug

Related Publications

N Mamelle, and P J Meunier, and R Dusan, and M Guillaume, and J L Martin, and A Gaucher, and A Prost, and G Zeigler, and P Netter
January 1993, Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA,
N Mamelle, and P J Meunier, and R Dusan, and M Guillaume, and J L Martin, and A Gaucher, and A Prost, and G Zeigler, and P Netter
March 1990, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research,
N Mamelle, and P J Meunier, and R Dusan, and M Guillaume, and J L Martin, and A Gaucher, and A Prost, and G Zeigler, and P Netter
January 1986, Acta Universitatis Carolinae. Medica,
N Mamelle, and P J Meunier, and R Dusan, and M Guillaume, and J L Martin, and A Gaucher, and A Prost, and G Zeigler, and P Netter
October 1991, Delaware medical journal,
N Mamelle, and P J Meunier, and R Dusan, and M Guillaume, and J L Martin, and A Gaucher, and A Prost, and G Zeigler, and P Netter
January 1990, Fortschritte der Medizin,
N Mamelle, and P J Meunier, and R Dusan, and M Guillaume, and J L Martin, and A Gaucher, and A Prost, and G Zeigler, and P Netter
February 1989, La Revue du praticien,
N Mamelle, and P J Meunier, and R Dusan, and M Guillaume, and J L Martin, and A Gaucher, and A Prost, and G Zeigler, and P Netter
February 1975, Polskie Archiwum Medycyny Wewnetrznej,
N Mamelle, and P J Meunier, and R Dusan, and M Guillaume, and J L Martin, and A Gaucher, and A Prost, and G Zeigler, and P Netter
January 1986, Clinical and investigative medicine. Medecine clinique et experimentale,
N Mamelle, and P J Meunier, and R Dusan, and M Guillaume, and J L Martin, and A Gaucher, and A Prost, and G Zeigler, and P Netter
January 1982, Clinical and investigative medicine. Medecine clinique et experimentale,
N Mamelle, and P J Meunier, and R Dusan, and M Guillaume, and J L Martin, and A Gaucher, and A Prost, and G Zeigler, and P Netter
December 1965, Annals of internal medicine,
Copied contents to your clipboard!